Breast – SLC6A1 negative invasive breast cancer of no special type (NST).
Breast – SLC6A1 negative invasive lobular breast cancer.
Colon – SLC6A1 negative colorectal adenocarcinoma.
Kidney – SLC6A1 negative clear cell carcinoma.
Kidney – SLC6A1 negative oncocytoma.
Kidney – SLC6A1 negative papillary renal cell carcinoma.
Lung – Adenocarcinoma with strong SLC6A1 immunostaining of tumor cells.
Lung – SLC6A1 negative adenocarcinoma.
Lung – SLC6A1 negative malignant mesothelioma (epitheloid).
Lung – SLC6A1 negative squamous cell carcinoma.
Oral cavity – SLC6A1 negative squamous cell carcinoma.
Ovary – SLC6A1 negative clear cell carcinoma.
Ovary – SLC6A1 negative endometroid carcinoma.
Ovary – SLC6A1 negative serous high-grade carcinoma.
Pharynx – SLC6A1 negative squamous cell carcinoma.
Prostate – SLC6A1 negative adenocarcinoma (Gleason 3+3=6). (2)
Prostate – SLC6A1 negative adenocarcinoma (Gleason 3+3=6). .jpeg
Testis – SLC6A1 negative seminoma.
Thyroid – SLC6A1 negative papillary carcinoma.
Urinary bladder – SLC6A1 negative muscle-invasive urothelial carcinoma.
Urinary bladder – SLC6A1 negative non-invasive papillary urothelial carcinoma (pTa). .jpeg